Indirect costs and related factors for patients with non-small cell lung cancer treated with targeted therapy in Vietnam

Chinh Van Nguyen; Huong Tran Thi Thanh; Kiet Tuan Pham Huy

Journal of Public Health and Development · 2026 · Tập 24(1) · 272-283

DOI Trang nguồn Toàn văn RIS BibTeX

Tóm tắt

The objective of our study was to estimate indirect costs and identify the factors affecting them. Additionally, we aimed to determine which age group impacts the component costs of the total indirect costs for non-small cell lung cancer (NSCLC) patients treated with targeted therapy. This cross-sectional descriptive study was conducted through interviews about indirect costs for one month, from October 2022 to December 2023, with 310 NSCLC patients at the Vietnam National Cancer Hospital. All indirect costs were standardized according to the Consumer Price Index (CPI) and converted to 2023 US dollars. The monthly mean total indirect costs for NSCLC patients were $96.0. The rate of caregivers' absence from work was 49%, and 37.7% of patients experienced income loss. However, the highest cost was income loss at $83.3, accounting for 86.8%, while caregivers' absence cost $10.1, accounting for 10.6% of the total indirect costs. The costs of patients’ absence and income loss were higher for patients under 60 years old (p < 0.001 for each group). Factors such as age (under 60), gender (male), and occupation (employed or unemployed) were identified as related to an increase in the total indirect costs for NSCLC patients compared to other groups (p < 0.05 for each group). Support from insurance agencies for patients’ absence and income loss is truly meaningful.

Nguyên văn tóm tắt của bài gốc đăng trên Journal of Public Health and Development.

Thông tin HTA

Thông tin thư mục do HERAC biên tập và đối chiếu với trang nguồn. Vui lòng đọc và trích dẫn tài liệu gốc.